Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells
Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells
复制标题
p-STAT3 的外泌体转移促进结直肠癌细胞获得性 5-FU 耐药性
DOI:
10.1186/s13046-019-1314-9
复制
发表时间:
2019
影响因子:
11.3
通讯作者:
Liu Huanliang
中科院分区:
文献类型:
--
作者:
Zhang Qian;Liu Rui Xian;Chan Ka Wo;Hu Jiancong;Zhang Jingdan;Wei Lili;Tan Huiliu;Yang Xiangling;Liu Huanliang
BackgroundAcquired resistance remains a limitation of the clinical use of 5-fluorouracil (5-FU). Because exosomes, are important vesicles participating in intercellular communication, their contribution to the development of acquired 5-FU resistance needs to be elucidated. In this study, we aimed to examine the underlying mechanisms of exosomes from 5-FU resistant cells (RKO/R) in sustaining acquired 5-FU resistance in sensitive cells (RKO/P).MethodsExosomes from a 5-FU-resistant cell line (RKO/R) and its parental cell line RKO/P were isolated and co-cultured with 5-FU-sensitive cells. Real-time cellular analysis (RTCA) and FACS analysis were used to examine cell viability and apoptosis. Exosomal protein profiling was performed using shotgun proteomics. Inhibitors and siRNAs were applied to study the involvement of selected proteins in 5-FU resistance. The effect of exosomal p-STAT3 (Tyr705) on the caspase cascade was examined by western blotting (WB) and high content analysis. Xenograft models were established to determine whether exosomal p-STAT3 can induce 5-FU resistance in vivo.ResultsOur results indicated that exosomes from RKO/R cells significantly promoted cell survival during 5-FU treatment. Proteomics and WB analysis results indicated that GSTP1 and p-STAT3 (Tyr705) were enriched in exosomes from RKO/R cells. Inhibition of p-STAT3 re-sensitized RKO/P cells to 5-FU via caspase cascade. Furthermore, p-STAT3 packaged by exosomes from RKO/R cells increased resistance of tumor cells to 5-FU in vivo.ConclusionsOur results reveal a novel mechanism by which p-STAT3-containing exosomes contribute to acquired 5-FU resistance in CRC. This study suggests a new option for potentiating the 5-FU response and finding biomarkers for chemotherapy resistance.